Category Archives: Research and Development

Good Participatory Practice TB drug trial guidelines lay groundwork for research, use of new treatments

By on .

If you consider all the years that time stood still in the world of tuberculosis drug research, the most compelling aspect of the Good Participatory Practice Guidelines for TB Drug Trials just released by a Critical Paths to TB Drug Regimens working group is that occasions exist for them to be used. With nearly half […]

TB drug trial yields gains in drug-resistant disease treatment

By on .

A study following patients who had  participated in a trial of a potential new treatment for drug-resistant tuberculosis has shown heartening results, with nearly three-quarters of patients who took the medicine for six months or longer showing “favorable outcomes”  — cured  or completed treatment —  according to a study published in the European Respiratory Journal. […]

HIV prevention: on the verge of transformation

By on .

A look at the recent AIDS Vaccine 2012 Conference shows range of prevention developments The following is a guest post from Margaret McGlynn, president and CEO of the International AIDS Vaccine Initiative (IAVI) and William Snow, director of the Global HIV Vaccine Enterprise. More than 1,000 HIV researchers and other professionals involved in HIV prevention […]